PRMT5 and telomere syndrome: By analyzing two large independent datasets, we show that PRMT5 overexpression is also associated with an increased risk of metastasis and adverse outcomes in patients with STS, suggesting important roles in sarcoma tumorigenesis and a potential role as a therapeutic target.